BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28292037)

  • 21. Male breast cancer: an 11 year review of 66 patients.
    McLachlan SA; Erlichman C; Liu FF; Miller N; Pintilie M
    Breast Cancer Res Treat; 1996; 40(3):225-30. PubMed ID: 8883964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
    Gudadze M; Kankava Q; Mariamidze A; Burkadze G
    Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and correlation of molecular subtypes of breast cancer with clinicopathological features.
    Akbar M; Akbar K; Naveed D
    J Ayub Med Coll Abbottabad; 2014; 26(3):290-3. PubMed ID: 25671929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The characteristics and risk factors of breast cancer patients trend distinctive regional differences: a cross-sectional study.
    Shirazi B; Niaz M; Khan MA
    J Pak Med Assoc; 2024 Apr; 74(4):672-676. PubMed ID: 38751260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histomorphological spetrum of breast lesions.
    Parajuli S; Koirala U; Khatri R; Acharya L; Suwal A
    J Nepal Health Res Counc; 2011 Apr; 9(1):48-51. PubMed ID: 22929713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
    Zhu X; Ying J; Wang F; Wang J; Yang H
    Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoma of the male breast: a study of 141 cases from northern Pakistan.
    Jamal S; Mamoon N; Mushtaq S; Luqman M
    Asian Pac J Cancer Prev; 2006; 7(1):119-21. PubMed ID: 16629528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast Cancer in Men: Clinical and Pathological Analysis of 817 Cases.
    Spreafico FS; Cardoso-Filho C; Cabello C; Sarian LO; Zeferino LC; Vale DB
    Am J Mens Health; 2020; 14(4):1557988320908109. PubMed ID: 32618495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Breast cancer in men: are there similarities with breast cancer in women?].
    Arnould N; Pouget O; Gharbi M; Brettes JP
    Gynecol Obstet Fertil; 2006 May; 34(5):413-9. PubMed ID: 16630739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretory carcinoma of breast: clinicopathologic study of 8 cases.
    Din NU; Idrees R; Fatima S; Kayani N
    Ann Diagn Pathol; 2013 Feb; 17(1):54-7. PubMed ID: 22832018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival.
    Winn JS; Baker MG; Fanous IS; Slack-Davis JK; Atkins KA; Dillon PM
    Oncology; 2016; 91(3):135-42. PubMed ID: 27355204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Male breast cancer: a multicentric study.
    Culell P; Solernou L; Tarazona J; Roma J; Martí E; Miguel A; Buxó J; Yanguas C; Badal JM
    Breast J; 2007; 13(2):213-5. PubMed ID: 17319872
    [No Abstract]   [Full Text] [Related]  

  • 33. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
    Sánchez-Muñoz A; Román-Jobacho A; Pérez-Villa L; Sánchez-Rovira P; Miramón J; Pérez D; Sáez MI; de Luque V; Medina L; Ramírez-Tortosa CL; Vicioso L; Medina JA; Ribelles N; Alba E
    Oncology; 2012; 83(4):228-33. PubMed ID: 22907070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast Cancer in Basra Oncology Center: A Clinico- Epidemiological Analysis.
    Abood RA
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2943-2946. PubMed ID: 30362328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological features and prognosis of lobular carcinoma in Egyptian breast cancer patients.
    Azim HA; Malek RA; Azim HA
    Womens Health (Lond); 2014 Sep; 10(5):511-8. PubMed ID: 25335542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
    Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
    Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Male breast cancer: a population-based comparison with female breast cancer in Hong Kong, Southern China: 1997-2006.
    Kwong A; Chau WW; Mang OW; Wong CH; Suen DT; Leung R; Wong K; Lee A; Shea C; Morse E; ; Law SC
    Ann Surg Oncol; 2014 Apr; 21(4):1246-53. PubMed ID: 24337541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
    Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological study of male breast cancer in Nigerians and a review of the literature.
    Olu-Eddo AN; Momoh MI
    Nig Q J Hosp Med; 2010; 20(3):121-4. PubMed ID: 21033319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.